Home
>
National Drug Code (NDC)
>
Equaline nicotine
Equaline nicotine - 41163-873-05 - (Nicotine Polacrilex)
Drug Information of Equaline nicotine
| Product NDC: | 41163-873 |
| Proprietary Name: | Equaline nicotine |
| Non Proprietary Name: | Nicotine Polacrilex |
| Active Ingredient(s): | 4 mg/1 & nbsp; Nicotine Polacrilex |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LOZENGE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Equaline nicotine
| Product NDC: | 41163-873 |
| Labeler Name: | Supervalu Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA077007 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060328 |
Package Information of Equaline nicotine
| Package NDC: | 41163-873-05 |
| Package Description: | 3 VIAL in 1 CARTON (41163-873-05) > 24 LOZENGE in 1 VIAL |
NDC Information of Equaline nicotine
| NDC Code | 41163-873-05 |
| Proprietary Name | Equaline nicotine |
| Package Description | 3 VIAL in 1 CARTON (41163-873-05) > 24 LOZENGE in 1 VIAL |
| Product NDC | 41163-873 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Nicotine Polacrilex |
| Dosage Form Name | LOZENGE |
| Route Name | ORAL |
| Start Marketing Date | 20060328 |
| Marketing Category Name | ANDA |
| Labeler Name | Supervalu Inc |
| Substance Name | NICOTINE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
